CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
zonisamide +1 moredrug
Likely dose
zonisamide 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00398918
NCT00398918N/ACompleted

Alcohol Self Administration Laboratory

Boston University·interventional·Posted Nov 14, 2006·Updated Jul 14, 2017

In Brief

A clinical study evaluating zonisamide and Placebo for Alcoholism. Completed, enrolled 10 participants across 1 site.

Detailed Summary

This is a pilot study in which our intent is to establish an alcohol administration laboratory in which we will be able to test the effect of the anticonvulsant medication zonisamide as compared to placebo on alcohol self administration and on cognitive functioning in non treatment seeking heavy users of alcohol. Our first goal is to establish the safety of zonisamide when used together with alcohol. Our second goal is to test the effect of an acute dose of zonisamide on alcohol consumption and show that it may reduce the consumption of alcohol. To achieve this goal we seek subjects with a history of heavy drinking to be tested on the self-administration procedures described below in two sessions with either zonisamide or placebo. These procedures will involve first, the administration of a challenge dose of ethanol to evaluate the effect of alcohol on performance on neuropsychological tests. This initial challenge will be followed by a period of alcohol self-administration in which the research subject can choose to select either ethanol or another reinforcer, money.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcoholism
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 14, 2006
Enrollment StartNov 1, 2006
Primary CompletionOct 1, 2007
Study CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 19.6 years ago

Interventions

zonisamidedrug

zonisamide (100 mg)one time

Placebodrug

Placebo Comparator